文献速递妇科肿瘤支持与姑息治疗

儿童无性细胞瘤:法国三项连续生殖细胞肿瘤临床研究(TGM-85/90/95)结果及远期效应分析

Paediatric dysgerminoma: Results of three consecutive French germ cell tumours clinical studies (TGM-85/90/95) with late effects study.
PubMed 文献 · Eur J Cancer · 2018-01-11

该研究纳入1985至2005年法国TGM-85/90/95方案治疗的48例≤18岁无性细胞瘤患者,中位随访14年全部存活完全缓解;保守手术联合铂类化疗预后极佳,但双侧卵巢切除率高且显著影响生育。

要点

  • 48例儿童无性细胞瘤患者中位随访14年全部完全缓解存活。
  • pS1期患者可仅行保守手术或等待观察,晚期患者接受铂类化疗。
  • 疾病和/或治疗导致12例需双侧卵巢切除,17例中2例卵巢早衰。

核心结论

  • 无性细胞瘤即使晚期,经保守手术联合铂类化疗预后也极佳,但双侧卵巢切除率高且对生育影响显著。

研究设计与样本

  • 法国多中心回顾性纳入1985至2005年TGM-85/90/95方案治疗的≤18岁无性细胞瘤患者48例,中位年龄12.8岁。

主要发现

  • 中位随访14年全部患者存活完全缓解,共5例事件:2例对侧无性细胞瘤、1例腹膜复发、2例第二肿瘤(畸胎瘤和黑色素瘤)。
  • 15例pS1期患者中7例未接受辅助治疗、6例淋巴结放疗、2例化疗;32例晚期患者中31例接受顺铂(n=25)或卡铂(n=8)方案化疗。
  • 17/36例有单侧卵巢切除且有妊娠意愿的患者中13例成功妊娠(5例医学辅助),2/17例出现卵巢早衰。
  • 铂类、异环磷酰胺或放疗后评估的25例患者中24例肾功能正常;17/36例铂类治疗患者听力评估示12例Brock 0级、3例1级、2例4级。

临床怎么用

  • 对完全切除的pS1期儿童无性细胞瘤可考虑保守手术联合等待观察或避免辅助治疗。
  • 晚期患者采用铂类为基础的化疗,并关注肾功能和听力监测。
  • 治疗决策需权衡双侧卵巢切除风险与生育力保护。

局限性

  • 回顾性研究且样本量有限,部分功能评估数据不完整。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

METHODS: French patients (≤18years) treated for dysgerminoma between 1985 and 2005 in TGM-85, 90, 95 protocols were included. Treatment was based on primary unilateral oophorectomy followed by prophylactic lymph node irradiation (1985-1998) or a wait-and-see strategy (1998-2005) for localised completely resected tumours (pS1) or by platinum-based chemotherapy for advanced diseases. RESULTS: Forty-eight patients (median age 12.8 years) were included. Six patients had gonadal dysgenesis. Two had bilateral dysgerminoma. Twenty-eight patients had loco-regional dissemination, seven with para-aortic lymph nodes. None had distant metastases. Primary surgery was performed in 47/48 patients. Among the 15 patients with pS1 tumour: seven did not receive adjuvant treatment, six had lymph node irradiation and two received chemotherapy. Among the 32 patients with advanced tumour, 31 received cisplatinum-based (n = 25) or carboplatin-based (n = 8) regimen with lymph node irradiation for one of them and one did not receive adjuvant treatment. With a median follow-up of 14 years, all patients are alive in complete remission. Five events occurred: 2 contralateral dysgerminomas, 1 peritoneal relapse and 2 second neoplasms (teratoma and melanoma). Bilateral oophorectomy was necessary for 12 patients. Desire of pregnancy was expressed for 17/36 patients with unilateral oophorectomy, which succeeded in 13 cases (5 medically assisted). 2/17 had ovarian failure. The renal function was normal in 24/25 evaluated patients treated with platinum, ifosfamide or irradiation. The hearing function was evaluated on 17/36 patients treated with platinum: 12 Brock grade-0, 3 brock grade-1 and 2 grade-4. CONCLUSION: Dysgerminoma has an excellent prognosis even in advanced cases with conservative surgery and platinum-based chemotherapy. However the disease and/or treatment resulted in a high rate of bilateral oophorectomies and a significant impact on future fertility.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Duhil de Bénazé G, Pacquement H, Faure-Conter C, et al. Paediatric dysgerminoma: Results of three consecutive French germ cell tumours clinical studies (TGM-85/90/95) with late effects study. Eur J Cancer. 2018. PMID: 29331749. doi:10.1016/j.ejca.2017.11.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。